Hey there, it’s Jamie, and for the past seven years, I’ve been on the ground as a PE stretch film supplier focused almost entirely on the pharmaceutical industry—so when folks ask me what makes our product different from the stretch film that wraps a pallet of retail snacks or a stack of construction supplies, I don’t just rattle off specs. I talk about the quality control hoops we jump through, because one tiny mistake in pharmaceutical packaging doesn’t just mean a damaged pallet; it can mean contaminated vaccines, expired meds, or even lost patient trust. Let’s break this down like we’re talking shop in a loading dock office (not a stuffy lab meeting), because that’s how I learned this stuff. PE Stretch Film
First off, let’s get one thing straight: pharmaceutical PE stretch film isn’t your run-of-the-mill LLDPE roll. For every batch we produce, we don’t just measure how well it stretches—we measure every single variable that could impact the sterility, integrity, or traceability of whatever’s wrapped inside. The FDA’s Code of Federal Regulations (CFR) Part 211 is the backbone of pharma packaging rules, right? So our QC team starts with incoming raw materials, not when the film is already on a roll. We source resin pellets from US-based suppliers that can provide full COAs (certificates of analysis) for every shipment, and before we even open a pallet of pellets, we run three quick checks: melt flow index, density, and residual additive content. Last year, we had a batch of pellets with a tiny bit too much slip agent—something that’s harmless for food packaging but would have left a sticky residue on vaccine vials if we’d used it. We caught that before it hit our extruders, and that’s non-negotiable here.
Next, the core performance standards that matter for pharma, not just for load stability. A lot of suppliers brag about stretch ratio, but in pharma, stretch retention is king. If you wrap a pallet of drug vials with film that stretches out and loses tension over time, the pallet can shift in a warehouse, the film can tear, and dust or microbial contaminants can sneak in. Our QC team tests stretch retention by pulling a sample of film to 300% elongation (standard for pallet wrapping) and holding it for 24 hours at 70°F and 50% humidity—conditions that mirror a typical warehouse. We require a minimum 90% retention, which is higher than the 85% standard for general industrial stretch film, because pharma pallets often sit in storage for months, not days. We also test puncture resistance, because a tiny thorn from a wooden pallet or a sharp edge on a plastic tray can tear film that’s fine for a grocery pallet but weak enough for vials. We use a standard pendulum puncture tester and require a minimum of 1.5 joules of force to puncture—again, higher than industry averages.
But here’s the part most people don’t talk about: extractables and leachables (E&L) testing. This is where we earn our keep in pharma. PE stretch film can leach plasticizers, oligomers, or other additives when exposed to moisture, temperature fluctuations, or even the products inside. If that leachate gets into a drug product, it can alter efficacy or cause adverse reactions. Our QC lab follows ISO 10993-18 guidelines for chemical characterization, and for every batch of film, we run extractables testing using simulated pharma conditions—like exposure to 50% ethanol (common solvent in liquid meds) and water at 40°C for 72 hours. We screen for over 200 compounds, and we only release batches that fall below the threshold set by the ICH Q7 guidelines, which is the global gold standard for active pharmaceutical ingredient (API) packaging. Last quarter, a customer told us they switched from a cheap overseas supplier because their film left a residue on insulin vials that made the vial labels smudge and left a weird taste when the product was tested—we never had that issue because E&L testing is a non-negotiable step, not an afterthought.
Sterility is another big one, but not in the way you might think. PE stretch film used for sterile drug packaging or for wrapping pallets of finished sterile products doesn’t itself need to be sterile, but it does need to not contribute to bioburden. Bioburden is the number of viable microorganisms on a surface, and for pharma packaging, we max out at 10 CFU per 100 cm² of film, per USP <1111> guidelines. We test this by swabbing random sections of film from every production run, incubating the swabs for 7 days at 30-35°C, and counting colonies. A few years back, we had a sensor on our oven misread, which caused a tiny spot on a roll to have a slightly higher bioburden—we caught it during testing, quarantined the roll, and fixed the sensor without sending bad product out. That’s the kind of QC that matters for pharma: not just end-of-line checks, but in-process checks every hour during production.
Traceability is also part of our QC process, and it’s a rule, not a nice-to-have, for pharma. Every roll of film we make has a unique batch number, lot number, and QR code that links to a full QC record: raw material COAs, E&L test results, stretch retention data, bioburden counts, and production dates. If a customer ever has an issue with a wrapped pallet, they can scan the code and see exactly where the film was made, what resin was used, and every test that was run. We also keep all QC records for 5 years, per FDA requirements, so even if a customer calls us back in 2028 with a problem from a 2023 batch, we can pull that data up in minutes. A lot of general stretch film suppliers throw traceability out the window once the roll leaves their dock, but in pharma, if you can’t trace a product back, you’re not just a supplier—you’re a liability.
Now, let’s talk about the tests that aren’t on a spec sheet but are just as important for our customers. We do on-site compatibility testing with every pharma line we supply. For example, if a customer wraps high-potency APIs, we test to make sure our film doesn’t electrostatically charge, which could cause cross-contamination between different API batches. We also check adhesion to pallet wraps—wait, no, not adhesion to pallets, but adhesion between film layers, to make sure that when you wrap a pallet, the film sticks to itself, not to the vials or trays. Last year, a vaccine maker told us that their old film would stick to the rubber stoppers on vials, causing the stoppers to shift during transit—we tested our film’s layer adhesion and adjusted our additive levels to fix that, and they haven’t had an issue since. That’s the stuff you don’t read about in standards, but it’s what separates a good PE stretch film supplier from a great one for pharma.
I know a lot of people in this industry talk about “regulatory compliance” like it’s a buzzword, but here’s the truth: all these standards we follow aren’t just to pass an audit. They’re to make sure that when a hospital gets a pallet of antibiotics, or a pharmacy gets a shipment of insulin, that film holding those vials together isn’t adding any risk. Our QC team isn’t just a group of guys in lab coats running tests—they’re the first line of defense between our product and the patients who use the meds we wrap.
If you’re a pharma packaging manager, or someone who sources materials for drug manufacturing, you know how critical quality is. Cut corners on stretch retention and you get torn film, contaminated pallets, and delayed shipments. Skip E&L testing and you risk product recalls. Ignore traceability and you’re stuck in a nightmare if something goes wrong. That’s why our QC process isn’t a set of boxes to check—it’s how we do business.
If you’re looking for a PE stretch film supplier that’s built for pharma, not just general packaging, I’d love to hop on a call, walk you through a batch of our film, and answer any questions you have about our standards. No hard sales pitch, just honest talk about what we do to make sure your products are safe, compliant, and arrive exactly as they should. Let’s connect.
PE Stretch Film References:
- U.S. Food and Drug Administration. (2023). Code of Federal Regulations Title 21 Part 211: Current Good Manufacturing Practice for Finished Pharmaceuticals.
- International Organization for Standardization. (2019). ISO 10993-18: Biological evaluation of medical devices – Part 18: Chemical characterization of medical devices.
- International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. (2021). ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients.
- United States Pharmacopeia Convention. (2022). USP <1111> Microbiological Examination of Nonsterile Products: Bioburden Tests.
Linyi Dongyi Import&Export Co., Ltd.
As one of the most professional pe stretch film manufacturers and suppliers in China, we offer a wide range of products with superior quality. We warmly welcome you to wholesale bulk customized pe stretch film from our factory. If you have any enquiry about quotation, please feel free to email us.
Address: 4 F, Zone A, Zhangjia Zhuxu Village, Lanshan District, Linyi City.
E-mail: donglai01972@gmail.com
WebSite: https://www.donglaipack.com/
